Download Poster (652.61 KB)

Publication
  • ASN •
  • 26 October, 2024 •
  • •

VALIANT: Phase 3 Trial of Pegcetacoplan for Patients With Native or Post-Transplant Recurrent C3G or Primary IC-MPGN

Carla M Nester, Andrew S Bomback, Gema Ariceta, Yahsou Delmas, Bradley P Dixon, Daniel P Gale, Larry A Greenbaum, Seung Hyeok Han, Nicole Isbel, Christoph Licht, Antonio Mastrangelo, Masashi Mizuno, Maria Izabel Neves de Holanda, Matthew C Pickering, Giuseppe Remuzzi, Nicole Van De Kar, Marina Vivarelli, Patrick D Walker, Dean Wallace, Daniel Zecher, Li Li, Zhongshen Wang, Luis López Lázaro, Johan Szamosi, Fadi Fakhouri

Available materials

Oral Presentation
Publication
  • ASN •
  • 24 October, 2024 •
  • •

Pegcetacoplan for post-transplant recurrent C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis in NOBLE: 52-week patient evolution

Anuja Java, Andrew S Bomback, David Kavanagh, Giuseppe Remuzzi, Gere Sunder-Plassmann, John Kanellis, Erica Daina, Patrick D. Walker, Zhongshen Wang, Zurish Ahmad, Fadi Fakhouri

Available materials

Poster
Publication
  • ASN •
  • 24 October, 2024 •
  • •

Long-term safety and efficacy of pegcetacoplan in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis: The long-term VALE extension study

Carla Nester, Gema Ariceta, Anwesha Mukherjee, Li Li, Johan Szamosi, Luis López Lázaro

Available materials

Poster
Publication
  • ASN •
  • 6 November, 2025 •
  • •

Effect of Nanoencapsulated Sirolimus plus Pegadricase (NASP) on Kidney Outcomes: Results from the Phase 3 DISSOLVE Studies

Minesh Rajpal, Vibeke Strand, Rehan Azeem, Ben Peace, Bhavisha Desai, Richard J. Johnson

Publication
  • ASN •
  • 6 November, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Reduces Gout Clinical Manifestations in Patients with Uncontrolled Gout (UG) and Stage 3 CKD

Nissreen Elfadawy, Puja Khanna, Rehan Azeem, Ben Peace, Bhavisha Desai, Yasir Qazi

Publication
  • ASN •
  • 6 November, 2025 •
  • •

Management of Uncontrolled Gout Among Nephrology Professionals: Findings from a Medical Chart Audit

Hyon Choi, Nana Kragh, Amod Athavale, Bhavisha Desai, Amal Gulaid, Abiola Oladapo, Brittany Smith, Kenneth Saag

Publication
  • ESPN •
  • 17 October, 2025 •
  • •

Pegcetacoplan halts disease progression and reduces proteinuria in paediatric patients with C3G and primary ​ IC-MPGN: Phase 3 VALIANT study results

Christoph Licht, Gema Ariceta, Yael Borovitz, Bradley P Dixon, Nayoa Fujita, Larry A Greenbaum, Antonio Mastrangelo, Nabil Melhem, Nicole CAJ Van de Kar, Marina Vivarelli, Dean Wallace, Virginia Taliadouros, Johan Szamosi, Katie Gordon, Zhongshen Wang, Carla M Nester

Sign up for alerts